A patent infringement suit filed by Merck & Co. Inc. against Teva Parenteral Medicines, Inc. relating to Cancidas is ongoing, Merck disclosed in its August 8, 2011, Form 10-Q filing…
A patent infringement suit filed by Merck & Co. Inc. against Apotex Corp. relating to Nasonex is pending, Merck disclosed in its August 8, 2011, Form 10-Q filing with the…
A patent infringement suit filed by Merck & Co. Inc. against Hamni USA, Inc. relating to Nexium is pending, Merck disclosed in its August 8, 2011, Form 10-Q filing with…
A patent infringement suit filed by Merck & Co. Inc. against Lupin Ltd. relating to Nexium is ongoing with no trial dates presently scheduled, Merck disclosed in its August 8,…
A patent infringement suit filed by Merck & Co. Inc. against Sandoz Inc. relating to AzaSite is pending, Merck disclosed in its August 8, 2011, Form 10-Q filing with the…
A patent infringement suit filed by Merck & Co. Inc. against Teva Parenteral Medicines, Inc. relating to Integrilin is pending, Merck disclosed in its August 8, 2011, Form 10-Q filing…
Merck & Co. Inc. continues to cooperate with the Federal Trade Commission after it received a Civil Investigative Demand regarding a patent settlement agreement it entered with Ranbaxy Laboratories Ltd.,…
A patent infringement suit filed by Pfizer Inc. against Teva Parenteral Medicines Inc. relating to Zyvox (linezolid) is pending.
In December 2009, Teva Parenteral notified the Company that it had filed…
Patent infringement actions filed by Pfizer Inc. against Watson and Ranbaxy Laboratories Limited relating to Rapamune (sirolimus) are pending.
In March 2010, Watson and Ranbaxy notified the Company that they had…
Patent infringement actions filed by Pfizer Inc. against Lupin Limited and Novel Laboratories, Inc. relating to Lyrica (pregabalin) are pending.
In August and November 2010, respectively, Lupin and Novel notified the…